For patients with newly diagnosed, standard-risk B-cell acute lymphoblastic leukemia (ALL) with an average or high risk for ...
Cellectis' strong cash position and pipeline updates boost confidence. See why CLLS stock could benefit from upcoming data in ...
Stay updated on promising new treatments for Diffuse Large B-cell Lymphoma and B-cell acute lymphoblastic leukemia in this ...
Brexucabtagene autoleucel showed comparable efficacy outcomes in patients aged 60 to 69 with relapsed/refractory B-cell acute ...
Hosted on MSN11h
Doctors diagnose 2-year-old with rare cancer after he bangs his toe on washing machineA family is struggling to cope after their 2-year-old son was diagnosed with a rare form of blood cancer, sharing the moment ...
For patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), obecabtagene autoleucel (obe-cel), an ...
Faith, love, and applesauce. It’s those three things that Chiles High graduate Taylor Koegel said got her through her battle with Acute Lymphoblastic Leukemia. It was a summer challenge that roped ...
Through the passing of his beloved father, standing alongside his daughter's battle with leukemia, and rebuilding a young ...
This year's MACC Star designer has a flair for style and art. Facing each day with grace and courage, 8-year-old Mary Schroeder of East Troy is redefining her acute lymphoblastic leukemia diagnosis.
The feud between Arcellx and Legend Biotech over their anti-BCMA CAR-T therapies for multiple myeloma is getting extra spicy ...
Long-term follow-up showed continued meaningful responses in patients with relapsed or refractory KMT2Ar acute leukemia who ...
Researchers from City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the United States, whose Los Angeles comprehensive cancer center is ranked among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback